0001104659-19-051350.txt : 20190925
0001104659-19-051350.hdr.sgml : 20190925
20190925163045
ACCESSION NUMBER: 0001104659-19-051350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190923
FILED AS OF DATE: 20190925
DATE AS OF CHANGE: 20190925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coffin Robert
CENTRAL INDEX KEY: 0001376492
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 191114544
MAIL ADDRESS:
STREET 1: C/O BIOVEX GROUP, INC.
STREET 2: 34 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 10801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822082553
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: 781-995-2443
MAIL ADDRESS:
STREET 1: 18 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
a4.xml
4
X0306
4
2019-09-23
0
0001737953
Replimune Group, Inc.
REPL
0001376492
Coffin Robert
C/O REPLIMUNE GROUP, INC.
18 COMMERCE WAY
WOBURN
MA
01801
1
1
0
0
President and CEO
Common Stock
2019-09-23
4
S
0
24250
17.05
D
2387868
D
The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
Following the sale reported on this Form 4, the reporting person continues to beneficially own 2,387,868 shares of the Issuer's common stock. The reporting person also holds options to acquire 712,599 shares of the Issuer's common stock, 216,804 of which are exercisable as of the date hereof.
/s/ Robert Coffin
2019-09-25